Your browser doesn't support javascript.
loading
Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease.
Zimmer, Jennifer A; Shcherbinin, Sergey; Devous, Michael D; Bragg, Sonja M; Selzler, Katherine J; Wessels, Alette M; Shering, Craig; Mullen, Jamie; Landry, John; Andersen, Scott W; Downing, AnnCatherine M; Fleisher, Adam S; Svaldi, Diana Otero; Sims, John R.
Afiliação
  • Zimmer JA; Eli Lilly and Company Indianapolis Indiana USA.
  • Shcherbinin S; Eli Lilly and Company Indianapolis Indiana USA.
  • Devous MD; Eli Lilly and Company Indianapolis Indiana USA.
  • Bragg SM; Eli Lilly and Company Indianapolis Indiana USA.
  • Selzler KJ; Eli Lilly and Company Indianapolis Indiana USA.
  • Wessels AM; Eli Lilly and Company Indianapolis Indiana USA.
  • Shering C; AstraZeneca, Neuroscience Biopharmaceuticals R&D Boston Massachusetts USA.
  • Mullen J; AstraZeneca, Neuroscience Biopharmaceuticals R&D Boston Massachusetts USA.
  • Landry J; Eli Lilly and Company Indianapolis Indiana USA.
  • Andersen SW; Eli Lilly and Company Indianapolis Indiana USA.
  • Downing AM; Eli Lilly and Company Indianapolis Indiana USA.
  • Fleisher AS; Eli Lilly and Company Indianapolis Indiana USA.
  • Svaldi DO; Eli Lilly and Company Indianapolis Indiana USA.
  • Sims JR; Eli Lilly and Company Indianapolis Indiana USA.
Alzheimers Dement (N Y) ; 7(1): e12123, 2021.
Article em En | MEDLINE | ID: mdl-33614894
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article